Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI). (Record no. 27441581)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01899 a2200493 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517165820.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201805s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1643-3750 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.12659/msm.903054 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Chen, Shuxia |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180507 |
245 00 - TITLE STATEMENT | |
Title | Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Medical science monitor : international medical journal of experimental and clinical research |
Date of publication, distribution, etc. | Aug 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 3824-3830 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adenosine |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Platelets |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clopidogrel |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Coronary Disease |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytochrome P-450 CYP2C19 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytochrome P-450 CYP2C19 Inhibitors |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drugs, Chinese Herbal |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Percutaneous Coronary Intervention |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Platelet Aggregation Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ticagrelor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ticlopidine |
General subdivision | analogs & derivatives |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhang, Yi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Lili |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Geng, Yanping |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gu, Jian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hao, Qingqing |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Hua |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Qi, Peng |
773 0# - HOST ITEM ENTRY | |
Title | Medical science monitor : international medical journal of experimental and clinical research |
Related parts | vol. 23 |
-- | p. 3824-3830 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.12659/msm.903054">https://doi.org/10.12659/msm.903054</a> |
Public note | Available from publisher's website |
No items available.